Free Trial

New York State Common Retirement Fund Sells 7,900 Shares of BlueLinx Holdings Inc. (NYSE:BXC)

BlueLinx logo with Construction background

New York State Common Retirement Fund reduced its position in BlueLinx Holdings Inc. (NYSE:BXC - Free Report) by 38.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 12,871 shares of the construction company's stock after selling 7,900 shares during the period. New York State Common Retirement Fund owned 0.16% of BlueLinx worth $965,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Exchange Traded Concepts LLC grew its holdings in shares of BlueLinx by 14.9% in the 1st quarter. Exchange Traded Concepts LLC now owns 3,113 shares of the construction company's stock worth $233,000 after acquiring an additional 404 shares during the period. Intech Investment Management LLC grew its holdings in shares of BlueLinx by 48.1% in the 4th quarter. Intech Investment Management LLC now owns 2,813 shares of the construction company's stock worth $287,000 after acquiring an additional 914 shares during the period. GAMMA Investing LLC grew its holdings in shares of BlueLinx by 42,890.0% in the 1st quarter. GAMMA Investing LLC now owns 12,897 shares of the construction company's stock worth $967,000 after acquiring an additional 12,867 shares during the period. PNC Financial Services Group Inc. acquired a new stake in shares of BlueLinx in the 4th quarter worth approximately $61,000. Finally, SG Americas Securities LLC grew its holdings in BlueLinx by 63.7% during the 1st quarter. SG Americas Securities LLC now owns 3,992 shares of the construction company's stock valued at $299,000 after buying an additional 1,554 shares during the last quarter. Institutional investors and hedge funds own 90.83% of the company's stock.

BlueLinx Stock Performance

Shares of BXC traded up $1.64 during trading hours on Friday, reaching $80.00. 71,833 shares of the company traded hands, compared to its average volume of 131,299. The stock has a market cap of $641.56 million, a P/E ratio of 17.86 and a beta of 1.90. The stock's fifty day moving average is $73.59 and its 200 day moving average is $80.93. BlueLinx Holdings Inc. has a 1-year low of $63.13 and a 1-year high of $134.79. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.73 and a current ratio of 4.16.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Wall Street Zen cut BlueLinx from a "hold" rating to a "sell" rating in a report on Friday, July 18th. Loop Capital decreased their price objective on BlueLinx from $120.00 to $115.00 and set a "buy" rating on the stock in a report on Monday, April 14th. DA Davidson cut BlueLinx from a "buy" rating to a "neutral" rating and set a $80.00 price objective on the stock. in a report on Friday, July 18th. Finally, Benchmark cut their target price on BlueLinx from $120.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $110.00.

Get Our Latest Analysis on BXC

About BlueLinx

(Free Report)

BlueLinx Holdings Inc, together with its subsidiaries, engages in the distribution of residential and commercial building products in the United States. It distributes specialty products, including engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products; and structural products, such as lumber, plywood, oriented strand boards, rebars and remesh, as well as other wood products that are used for structural support in construction projects.

Further Reading

Institutional Ownership by Quarter for BlueLinx (NYSE:BXC)

Should You Invest $1,000 in BlueLinx Right Now?

Before you consider BlueLinx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlueLinx wasn't on the list.

While BlueLinx currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines